SS-31

Description

Cellular biologists inspect inner membrane stabilization by introducing the SS-31 mitochondrial peptide into damaged organelle environments. This targeting agent binds directly to cardiolipin molecules to shield crucial bioenergetic structures.

Core Research Focus

• Organelle Membrane Protection: Allows labs to observe how targeted tetrapeptide structures protect inner cellular systems from rapid decay.

• ATP Production & Bioenergetics: Enables specialists to monitor respiratory chain adaptation, microvascular performance, and matrix recovery using pure SS-31 mitochondrial peptide.

• Comparative Research Options: To evaluate cardiolipin preservation alongside dual mitochondrial and peripheral tissue repair models, explore our SS-31 + ARA-290 Peptide Blend. For synthesis standards between laboratory and therapeutic grade compounds, read our guide on Research Peptides vs Pharmaceutical Peptides. You can also review our laboratory standards on our About Us Page.

Technical Specifications

Handling & Storage Guidelines

• Storage Condition: Lock the dry vial away in deep freeze storage at -20°C for long-term stability, protected from direct light exposure.

• Reconstitution & Handling: Reconstitute gently by running liquid media down the inside vial wall to preserve structural integrity. For indexed literature and scientific studies on cardiolipin-targeting tetrapeptides, consult PubMed SS-31 Studies.

• Usage Safety: Protect from sharp temperature shifts post-reconstitution and avoid multiple freeze-thaw cycles to keep the setup stable.

Research Disclaimer: This compound is synthesized strictly for laboratory research and development purposes. It is not intended for human therapeutic, diagnostic, or clinical use.